Pulse Biosciences (PLSE) Total Non-Current Liabilities (2016 - 2025)

Pulse Biosciences' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $13.9 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities fell 21.11% year-over-year to $13.9 million; the TTM figure through Dec 2025 stood at $13.9 million (down 21.11% YoY), while the FY2025 annual figure was $13.9 million, down 21.11% from the prior year.
• Total Non-Current Liabilities was $13.9 million for Q4 2025 at Pulse Biosciences, down from $16.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $81.4 million in Q3 2022 to a low of $13.8 million in Q3 2023.
• Historically, Total Non-Current Liabilities has averaged $30.3 million across 5 years, with a median of $17.2 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities surged 497.24% in 2021, then plunged 83.04% in 2023.
• A 5-year view of Total Non-Current Liabilities shows it stood at $14.8 million in 2021, then jumped by 441.6% to $80.1 million in 2022, then slumped by 81.54% to $14.8 million in 2023, then gained by 18.95% to $17.6 million in 2024, then retreated by 21.11% to $13.9 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $13.9 million (Q4 2025), $16.1 million (Q3 2025), and $15.8 million (Q2 2025), per Business Quant data.